Sign In
Buy LLY
$1,185.71
-7.09 (-0.594%)
At Close: Aug 07, 2026
3 Top Stocks That'll Make Smart Investors Rich
05:00am, Monday, 27'th Nov 2023
Investors should select a variety of companies with strong earnings prospects and hold on for a number of years. It's a great idea to include companies with a track record of success and leadership in
3 Fantastic Dividend Stocks to Buy Sooner Rather Than Later
06:55am, Sunday, 26'th Nov 2023
AbbVie is a Dividend King with a bright future. Eli Lilly's dividend is just icing on the cake, with the company's growth prospects taking center stage.
Eli Lilly and Novo Nordisk will remain winners in the weight-loss category: Barclays' Emily Field
09:52am, Friday, 24'th Nov 2023
Emily Field, Barclays, joins 'Squawk Box' to discuss the latest news in the weight-loss drug market, the news to watch out for next year, and how investors should play the weight-loss drug market.
Eli Lilly (LLY) Stock Outperforms Industry YTD: Here's Why
09:46am, Thursday, 23'rd Nov 2023
Lilly (LLY) is making rapid pipeline progress in areas like obesity, diabetes and Alzheimer's. Mounjaro and Zepbound are expected to be key top-line drivers for Lilly.
Will Eli Lilly Be Worth More Than Tesla by 2027?
09:05am, Thursday, 23'rd Nov 2023
Eli Lilly's shares climbed rapidly in recent years. The pharma giant's track record of bringing highly successful drugs into the market means there's a long growth runway.
3 Healthcare Stocks to Scoop Up as They Change the Medical Landscape
01:13pm, Wednesday, 22'nd Nov 2023
The U.S. continues to spend more money on healthcare than any other country. Healthcare spending totaled $4.3 trillion, according to the American Medical Association.
New ETF invested in Ozempic maker and exposed to other obesity drugs falls in first day of trade
08:01am, Wednesday, 22'nd Nov 2023
A new ETF hit the market Tuesday, creating buzz for its exposure to popular weight-loss drugs, while expanding the roster of thematic ETFs available for investors willing to pay up for stock-picking p
ABBV vs. LLY: Which Stock Should Value Investors Buy Now?
12:47pm, Tuesday, 21'st Nov 2023
Investors with an interest in Large Cap Pharmaceuticals stocks have likely encountered both AbbVie (ABBV) and Eli Lilly (LLY). But which of these two stocks offers value investors a better bang for th
GLOBALT Investments' Keith Buchanan on his top stock picks: WMT, LLY, JPM
09:09am, Tuesday, 21'st Nov 2023
Keith Buchanan, GLOBALT Investments senior portfolio manager, joins 'Squawk Box' to discuss his top stock picks, including Walmart, Eli Lilly, and JPMorgan Chase.
Ignore Eli Lilly. These 2 Stocks Are Better Buys Right Now
05:30am, Tuesday, 21'st Nov 2023
Pfizer and AbbVie face headwinds right now, but their long-term outlooks remain bright. Both stocks trade for a bargain today.
Lilly (LLY) to Build $2.5B Plant to Meet Increased Drug Demand
12:47pm, Monday, 20'th Nov 2023
Through this expansion, Eli Lilly (LLY) intends to expand its global manufacturing footprint to support the rising demand for its diabetes and obesity portfolio.
Medicare's exclusion of weight-loss drug coverage under fire
12:26pm, Monday, 20'th Nov 2023
Medicare's decades-old exclusion of weight-loss drug coverage is coming under scrutiny amid mounting evidence that Wegovy and similar medications have health benefits that extend well beyond shedding
Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know
10:31am, Monday, 20'th Nov 2023
Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Billionaires Bullish on Big Tech: ETFs in Focus
09:46am, Monday, 20'th Nov 2023
The latest 13-F filings of billionaires indicate that most are still bullish on big techs.
Eli Lilly Just Got One Step Closer to Dethroning Ozempic. Time to Buy the Stock?
06:05am, Sunday, 19'th Nov 2023
Eli Lilly's approval for its obesity drug Zepbound is a huge step forward in its attempt to take market share from its top rival Novo Nordisk. The combination of Mounjaro and Zepbound could reach near
